1996
DOI: 10.1016/0165-0378(96)87783-7
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

4
96
1

Year Published

1999
1999
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(101 citation statements)
references
References 0 publications
4
96
1
Order By: Relevance
“…The trophoblastic cells in human placenta lack classical HLA class I and class II antigens, with the exception of the expression of HLA-C during the first trimester (1,2). Although this condition prevents allorecognition and lysis by maternal T lymphocytes, it poses the problem of how trophoblastic cells can escape lysis mediated by natural killer (NK) cells.…”
mentioning
confidence: 99%
“…The trophoblastic cells in human placenta lack classical HLA class I and class II antigens, with the exception of the expression of HLA-C during the first trimester (1,2). Although this condition prevents allorecognition and lysis by maternal T lymphocytes, it poses the problem of how trophoblastic cells can escape lysis mediated by natural killer (NK) cells.…”
mentioning
confidence: 99%
“…However, a complete lack of class I MHC molecules on EVT cells would render these cells susceptible to attack by maternal NK cells, a phenomenon known as the missing self (2). It has now become evident that trophoblast cells do express the nonclassical class I MHC molecules HLA-G (3, 4), HLA-E (5), as well as the classical class I MHC molecule HLA-C, which is expressed mainly during the first trimester (6,7).…”
mentioning
confidence: 99%
“…If the MEM and 3D12 mAbs are widely HLA-A, -B, -C cross-reactive, coexpression with HLA-C may be particularly misleading. Besides being prone to unfolding, HLA-C is the only classical HLA class I molecule expressed in the cytotrophoblast [16]. Thus, expression of HLA-E at the fetal-maternal interface and in human tumors originating from HLA-E-negative normal counterparts [17], as well as association with tumor prognosis ([12, 18] and reviewed therein) may all be questionable.…”
mentioning
confidence: 99%